This review summarizes the up-to-date information about GLUT12 physiological role and its implication in obesity and cancer, opening new perspectives to consider this transporter as a therapeutic target. This evidence concerns the gene SLC2A12 and obesity due to melanocortin 4 receptor deficiency.